4,382
Views
47
CrossRef citations to date
0
Altmetric
Original Articles

Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial

, , , , ORCID Icon, , , , , , & show all
Pages 129-138 | Received 23 May 2018, Accepted 05 Aug 2018, Published online: 16 Nov 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.